Dyslipoproteinemia and xanthomatosis.
The cutaneous markers associated with dyslipoproteinemia are reviewed in the context of the current view of lipid and lipoprotein metabolism. The utility of determining the plasma levels of lipoproteins and certain apoproteins in children or adults with xanthomas or xanthelasma is discussed. We hope that early identification and appropriate treatment of such patients will reduce the morbidity and mortality from the two major complications of dyslipoproteinemia--atherosclerotic cardiovascular disease and pancreatitis.
D000293:Adolescent; D000328:Adult; D001053:Apolipoproteins / Q000097:blood; D001161:Arteriosclerosis / Q000503:physiopathology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000145:classification; D006938:Hyperlipoproteinemia Type II / Q000503:physiopathology; D006952:Hyperlipoproteinemia Type III / Q000503:physiopathology; D006951:Hyperlipoproteinemias / Q000145:classification; D007223:Infant; D007231:Infant, Newborn; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood* / Q000502:physiology; D008297:Male; D012871:Skin Diseases / Q000097:blood*; D014972:Xanthogranuloma, Juvenile / Q000097:blood* / Q000503:physiopathology; D014973:Xanthomatosis / Q000097:blood* / Q000503:physiopathology
D001053:Apolipoproteins; D008055:Lipids; D008074:Lipoproteins